Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 113

1.

Mechanisms of N-oleoyldopamine activation of central histaminergic neurons.

De Luca R, Mazur K, Kernder A, Suvorava T, Kojda G, Haas HL, Sergeeva OA.

Neuropharmacology. 2018 Sep 13;143:327-338. doi: 10.1016/j.neuropharm.2018.09.006. [Epub ahead of print]

PMID:
30219501
2.

The role of bradykinin receptor type 2 in spontaneous extravasation in mice skin: implications for non-allergic angio-oedema.

Bisha M, Dao VT, Gholamreza-Fahimi E, Vogt M, van Zandvoort M, Weber S, Bas M, Khosravani F, Kojda G, Suvorava T.

Br J Pharmacol. 2018 May;175(10):1607-1620. doi: 10.1111/bph.14166. Epub 2018 Apr 14.

PMID:
29465763
3.
4.

Nitric oxide up-regulates endothelial expression of angiotensin II type 2 receptors.

Dao VT, Medini S, Bisha M, Balz V, Suvorava T, Bas M, Kojda G.

Biochem Pharmacol. 2016 Jul 15;112:24-36. doi: 10.1016/j.bcp.2016.05.011. Epub 2016 May 26.

PMID:
27235748
5.

Effects of varenicline on alpha4-containing nicotinic acetylcholine receptor expression and cognitive performance in mice.

Lange-Asschenfeldt C, Schäble S, Suvorava T, Fahimi EG, Bisha M, Stermann T, Henning U, Kojda G.

Neuropharmacology. 2016 Aug;107:100-110. doi: 10.1016/j.neuropharm.2016.03.025. Epub 2016 Mar 21.

PMID:
27012889
6.

Preservation of Endothelial and Smooth Muscle Function of Human Saphenous Vein Transplants.

Bas M, Luther B, Knopf A, Suvorava T, Kojda G.

Exp Clin Transplant. 2016 Feb;14(1):86-92.

7.

Deletion of Hyaluronan Synthase 3 Inhibits Neointimal Hyperplasia in Mice.

Kiene LS, Homann S, Suvorava T, Rabausch B, Müller J, Kojda G, Kretschmer I, Twarock S, Dai G, Deenen R, Hartwig S, Lehr S, Köhrer K, Savani RC, Grandoch M, Fischer JW.

Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):e9-16. doi: 10.1161/ATVBAHA.115.306607. Epub 2015 Nov 19.

8.

Identification of histaminergic neurons through histamine 3 receptor-mediated autoinhibition.

De Luca R, Suvorava T, Yang D, Baumgärtel W, Kojda G, Haas HL, Sergeeva OA.

Neuropharmacology. 2016 Jul;106:102-15. doi: 10.1016/j.neuropharm.2015.08.025. Epub 2015 Aug 19.

PMID:
26297536
9.

Angioedema induced by cardiovascular drugs: new players join old friends.

Bas M, Greve J, Strassen U, Khosravani F, Hoffmann TK, Kojda G.

Allergy. 2015 Oct;70(10):1196-200. doi: 10.1111/all.12680. Epub 2015 Jul 15. Review.

PMID:
26119220
10.

Icatibant in ACE-inhibitor-induced angioedema.

Baş M, Hoffmann TK, Kojda G.

N Engl J Med. 2015 May 7;372(19):1867-8. doi: 10.1056/NEJMc1503671. No abstract available.

11.

Impact of eNOS-Dependent Oxidative Stress on Endothelial Function and Neointima Formation.

Suvorava T, Nagy N, Pick S, Lieven O, Rüther U, Dao VT, Fischer JW, Weber M, Kojda G.

Antioxid Redox Signal. 2015 Sep 20;23(9):711-23. doi: 10.1089/ars.2014.6059. Epub 2015 Jun 8.

12.

Sustained hypertension despite endothelial-specific eNOS rescue in eNOS-deficient mice.

Suvorava T, Stegbauer J, Thieme M, Pick S, Friedrich S, Rump LC, Hohlfeld T, Kojda G.

Biochem Biophys Res Commun. 2015 Mar 13;458(3):576-583. doi: 10.1016/j.bbrc.2015.01.152. Epub 2015 Feb 11.

PMID:
25680465
13.

A randomized trial of icatibant in ACE-inhibitor-induced angioedema.

Baş M, Greve J, Stelter K, Havel M, Strassen U, Rotter N, Veit J, Schossow B, Hapfelmeier A, Kehl V, Kojda G, Hoffmann TK.

N Engl J Med. 2015 Jan 29;372(5):418-25. doi: 10.1056/NEJMoa1312524.

14.

Effect of C1-Esterase-inhibitor in angiotensin-converting enzyme inhibitor-induced angioedema.

Greve J, Bas M, Hoffmann TK, Schuler PJ, Weller P, Kojda G, Strassen U.

Laryngoscope. 2015 Jun;125(6):E198-202. doi: 10.1002/lary.25113. Epub 2015 Jan 13.

PMID:
25583256
15.

Stability of murine bradykinin type 2 receptor despite treatment with NO, bradykinin, icatibant, or C1-INH.

Khosravani F, Suvorava T, Dao VT, Brockmann N, Kocgirli O, Herbst FF, Valcaccia S, Kassack MU, Bas M, Kojda G.

Allergy. 2015 Mar;70(3):285-94. doi: 10.1111/all.12556. Epub 2014 Dec 24.

PMID:
25477154
16.

Bradykinin in health and disease: proceedings of the Bradykinin Symposium 2012, Berlin 23-24 August 2012.

Magerl M, Bader M, Gompel A, Joseph K, Kaplan AP, Kojda G, Renné T, Wirth M, Maurer M, Church MK.

Inflamm Res. 2014 Mar;63(3):173-8. doi: 10.1007/s00011-013-0693-1. Epub 2013 Dec 8. No abstract available.

PMID:
24316865
17.

Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin.

Both C, Kojda G, Lange-Asschenfeldt C.

Expert Rev Neurother. 2014 Jan;14(1):29-38. doi: 10.1586/14737175.2014.853617. Epub 2013 Nov 22. Review.

PMID:
24308277
18.

Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice.

Potthoff SA, Fähling M, Clasen T, Mende S, Ishak B, Suvorava T, Stamer S, Thieme M, Sivritas SH, Kojda G, Patzak A, Rump LC, Stegbauer J.

Hypertension. 2014 Feb;63(2):265-72. doi: 10.1161/HYPERTENSIONAHA.113.02289. Epub 2013 Nov 4.

PMID:
24191281
19.

Redox-mediated mechanisms and biological responses of copper-catalyzed reduction of the nitrite ion in vitro.

Opländer C, Rösner J, Gombert A, Brodski A, Suvorava T, Grotheer V, van Faassen EE, Kröncke KD, Kojda G, Windolf J, Suschek CV.

Nitric Oxide. 2013 Nov 30;35:152-64. doi: 10.1016/j.niox.2013.10.004. Epub 2013 Oct 16.

PMID:
24140456
20.

Epidemiology, symptoms, and treatment characteristics of hyponatremic psychiatric inpatients.

Lange-Asschenfeldt C, Kojda G, Cordes J, Hellen F, Gillmann A, Grohmann R, Supprian T.

J Clin Psychopharmacol. 2013 Dec;33(6):799-805. doi: 10.1097/JCP.0b013e3182a4736f.

PMID:
24052056

Supplemental Content

Loading ...
Support Center